Spero Therapeutics Inc (SPRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SPRO | AGEN | FATE | ||
| Company | Spero Therapeutics Inc | Agenus Inc | Fate Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.39 | 3.60 | 1.1500 | ||
| High | 2.46 | 3.68 | 1.2850 | ||
| Low | 2.37 | 3.54 | 1.1500 | ||
| Latest | 2.41 | 3.56 | 1.2200 | ||
| Change | +0.04 | unch | +0.0900 | ||
| % Change | +1.69% | unch | +7.96% | ||
| Volume | 185,200 | 255,400 | 2,036,000 | ||
| 20-Day Average Volume | 292,835 | 535,315 | 1,578,455 | ||
| Previous Close | 2.37 | 3.56 | 1.1300 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.39 | 3.38 | 1.2645 | ||
| 20-Day Raw Stochastic | 50.85% | 55.00% | 32.14% | ||
| 20-Day Relative Strength | 51.67 | 53.63 | 49.44 | ||
| Weighted Alpha | +8.64 | +11.29 | -0.49 | ||
| Today's Opinion | 88% Buy | 40% Sell | 40% Buy | ||
| Previous Opinion | 64% Buy | 40% Sell | 8% Sell | ||
| Last Month's Opinion | 16% Sell | 88% Sell | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.03% since 03/18/26 | -5.32% since 03/18/26 | +15.09% since 03/18/26 | ||
| Low | 2.29 on 03/24/26 | 3.51 on 03/24/26 | 1.0400 on 03/19/26 | ||
| High | 2.48 on 03/19/26 | 3.87 on 03/19/26 | 1.2850 on 03/25/26 | ||
| 1-Month | |||||
| %Chg | +8.56% since 02/25/26 | +10.22% since 02/25/26 | -17.57% since 02/25/26 | ||
| Low | 2.11 on 03/03/26 | 2.90 on 03/09/26 | 1.0400 on 03/19/26 | ||
| High | 2.70 on 03/17/26 | 4.10 on 03/17/26 | 1.6000 on 02/27/26 | ||
| 3-Month | |||||
| %Chg | +2.99% since 12/24/25 | +6.27% since 12/24/25 | +20.79% since 12/24/25 | ||
| Low | 2.10 on 02/03/26 | 2.71 on 02/05/26 | 0.9632 on 12/30/25 | ||
| High | 2.70 on 03/17/26 | 4.87 on 01/14/26 | 1.6950 on 02/25/26 | ||
| 6-Month | |||||
| %Chg | +24.23% since 09/25/25 | -8.72% since 09/25/25 | +25.67% since 09/25/25 | ||
| Low | 1.84 on 09/30/25 | 2.71 on 02/05/26 | 0.9500 on 11/14/25 | ||
| High | 2.75 on 11/12/25 | 4.87 on 01/14/26 | 1.9399 on 10/27/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 133,523 | 136,697 | 131,377 | ||
| Shares Outstanding, K | 56,339 | 38,398 | 116,263 | ||
| Annual Sales | 47,980,000 | 114,200,000 | 6,650,000 | ||
| Annual Net Income | -68,570,000 | 120,000 | -136,320,000 | ||
| Last Quarter Sales | 5,440,000 | 34,200,000 | 1,370,000 | ||
| Last Quarter Net Income | -7,380,000 | -10,580,000 | -32,370,000 | ||
| 60-Month Beta | 1.45 | 1.57 | 2.19 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.13 on 11/13/25 | 0.56 on 03/16/26 | -0.27 on 02/26/26 | ||
| Latest Earnings Date | 03/26/26 | 05/11/26 | 05/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | 09/16/15 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 7.85 | 0.00 | ||